Apogee Therapeutics (APGE) Short Interest Ratio & Short Volume → This Wall Street stock prediction just went viral (From Chaikin Analytics) (Ad) Free APGE Stock Alerts $53.30 -0.70 (-1.30%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Apogee Therapeutics Short Interest DataCurrent Short Volume4,840,000 sharesPrevious Short Volume4,550,000 sharesChange Vs. Previous Month+6.37%Dollar Volume Sold Short$243.45 millionShort Interest Ratio / Days to Cover7.2Last Record DateApril 30, 2024Outstanding Shares42,920,000 sharesFloat Size34,560,000 sharesShort Percent of Float14.00%Today's Trading Volume656,802 sharesAverage Trading Volume586,326 sharesToday's Volume Vs. Average112% Short Selling Apogee Therapeutics ? Sign up to receive the latest short interest report for Apogee Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAPGE Short Interest Over TimeAPGE Days to Cover Over TimeAPGE Percentage of Float Shorted Over Time Ad Market Moving TrendsTop 5 AI Stocks to Buy for 20245 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In" Apogee Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,840,000 shares $243.45 million +6.4%14.0%7.2 $50.30 4/15/20244,550,000 shares $241.47 million -1.1%13.0%6.6 $53.07 3/31/20244,600,000 shares $305.67 million +50.8%13.1%6.8 $66.45 3/15/20243,050,000 shares $208.35 million -2.6%9.8%4.8 $68.31 2/29/20243,130,000 shares $108.99 million -5.2%14.6%6.1 $34.82 2/15/20243,300,000 shares $117.94 million -12.0%15.4%9.9 $35.74 1/31/20243,750,000 shares $125.63 million No Change17.6%11.4 $33.50 APGE Short Interest - Frequently Asked Questions What is Apogee Therapeutics' current short interest? Short interest is the volume of Apogee Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 4,840,000 shares of APGE short. 14.00% of Apogee Therapeutics' shares are currently sold short. Learn More on Apogee Therapeutics' current short interest. What is a good short interest ratio for Apogee Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. APGE shares currently have a short interest ratio of 7.0. Learn More on Apogee Therapeutics's short interest ratio. Which institutional investors are shorting Apogee Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Apogee Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Apogee Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 14.00% of Apogee Therapeutics' floating shares are currently sold short. Is Apogee Therapeutics' short interest increasing or decreasing? Apogee Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,840,000 shares, an increase of 6.4% from the previous total of 4,550,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Apogee Therapeutics' float size? Apogee Therapeutics currently has issued a total of 42,920,000 shares. Some of Apogee Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Apogee Therapeutics currently has a public float of 34,560,000 shares. How does Apogee Therapeutics' short interest compare to its competitors? 14.00% of Apogee Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Apogee Therapeutics: Vericel Co. (9.22%), Kymera Therapeutics, Inc. (16.15%), Twist Bioscience Co. (20.49%), Recursion Pharmaceuticals, Inc. (24.98%), Ginkgo Bioworks Holdings, Inc. (20.84%), Denali Therapeutics Inc. (8.16%), Beam Therapeutics Inc. (17.03%), Fusion Pharmaceuticals Inc. (4.64%), Inhibrx, Inc. (4.18%), Arcellx, Inc. (8.89%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Apogee Therapeutics stock? Short selling APGE is an investing strategy that aims to generate trading profit from Apogee Therapeutics as its price is falling. APGE shares are trading down $0.66 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Apogee Therapeutics? A short squeeze for Apogee Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APGE, which in turn drives the price of the stock up even further. How often is Apogee Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APGE, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Vericel Short Interest Data Kymera Therapeutics Short Interest Data Twist Bioscience Short Interest Data Recursion Pharmaceuticals Short Interest Data Ginkgo Bioworks Short Interest Data Denali Therapeutics Short Interest Data Beam Therapeutics Short Interest Data Fusion Pharmaceuticals Short Interest Data Inhibrx Short Interest Data Arcellx Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APGE) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsTop 5 AI Stocks to Buy for 2024Market Moving TrendsThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTop 5 Tech Stocks to Buy for 2024Daily Market AlertsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News